These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 19874571

  • 1. Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part I.
    Hay JW, Smeeding J, Carroll NV, Drummond M, Garrison LP, Mansley EC, Mullins CD, Mycka JM, Seal B, Shi L.
    Value Health; 2010; 13(1):3-7. PubMed ID: 19874571
    [Abstract] [Full Text] [Related]

  • 2. Good research practices for measuring drug costs in cost-effectiveness analyses: an international perspective: the ISPOR Drug Cost Task Force report--Part VI.
    Shi L, Hodges M, Drummond M, Ahn J, Li SC, Hu S, Augustovski F, Hay JW, Smeeding J.
    Value Health; 2010; 13(1):28-33. PubMed ID: 19883403
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
    Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, Orlewska E, Watkins J, Trueman P.
    Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
    [Abstract] [Full Text] [Related]

  • 5. Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report--Part II.
    Garrison LP, Mansley EC, Abbott TA, Bresnahan BW, Hay JW, Smeeding J.
    Value Health; 2010; 13(1):8-13. PubMed ID: 19883405
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
    McGhan WF, Al M, Doshi JA, Kamae I, Marx SE, Rindress D.
    Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.
    Weinstein MC, O'Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, Luce BR, ISPOR Task Force on Good Research Practices--Modeling Studies.
    Value Health; 2003; 6(1):9-17. PubMed ID: 12535234
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A Transparent and Consistent Approach to Assess US Outpatient Drug Costs for Use in Cost-Effectiveness Analyses.
    Levy J, Rosenberg M, Vanness D.
    Value Health; 2018 Jun; 21(6):677-684. PubMed ID: 29909872
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report.
    Malone DC, Ramsey SD, Patrick DL, Johnson FR, Mullins CD, Roberts MS, Willke RJ, Marshall DA.
    Value Health; 2020 Apr; 23(4):409-415. PubMed ID: 32327155
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2].
    Garrison LP, Pauly MV, Willke RJ, Neumann PJ.
    Value Health; 2018 Feb; 21(2):124-130. PubMed ID: 29477389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.